Back to top
more

uniQure (QURE)

(Delayed Data from NSDQ)

$8.57 USD

8.57
1,371,992

+0.49 (6.06%)

Updated Jul 25, 2024 04:00 PM ET

After-Market: $8.56 -0.01 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value F Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (83 out of 250)

Industry: Medical - Biomedical and Genetics

Better trading starts here.

Zacks News

Axovant (AXON) Gains on Licensing Deal with Oxford BioMedica

Axovant Sciences' (AXON) shares rally, following news of a licensing deal for AXO-LentiPD from Oxford BioMedica for Parkinson's disease.

    Madeleine Johnson headshot

    Why UniQure (QURE) Stock is Skyrocketing Today

    On Thursday, shares of leading gene therapy company uniQure (QURE) are skyrocketing, up over 50% in morning trading after it announced that it will launch a pivotal study next year testing AMT-061, the company's promising gene therapy candidate to treat patients with hemophilia B.

      uniQure (QURE) in Focus: Stock Moves 11.9% Higher

      uniQure (QURE) saw its shares rise nearly 12% on the day.

        uniQure N.V. (QURE) Shows Strength: Stock Moves 9.1% Higher

        uniQure N.V. (QURE) was a big mover last session, as the company saw its shares rise a little above 9% on the day.

          Arpita Dutt headshot

          5 Drug Stocks That Could Be Big Winners this Earnings Season

          Here is a look at five companies including Pfizer (PFE) that sport a favorable Zacks Rank and have a positive earnings ESP.

            Can The Uptrend Continue for uniQure N.V. (QURE)?

            Investors certainly have to be happy with uniQure N.V. (QURE) and its short term performance

              Will Uniqure (QURE) Continue to Surge Higher?

              As of late, it has definitely been a great time to be an investor in Uniqure NV (QURE).

                uniQure (QURE): Strong Industry, Solid Earnings Estimate Revisions

                uniQure (QURE) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Industry Rank perspective.